Healthcare - Biotechnology - NASDAQ - US
$ 49.58
-7.45 %
$ 5.52 B
Market Cap
-53.89
P/E
CASH FLOW STATEMENT
-73.4 M
OPERATING CASH FLOW
-179 M
INVESTING CASH FLOW
271 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Viking Therapeutics, Inc.
| Net Income | -85.9 M |
| Depreciation & Amortization | 292 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 16.8 M |
| Change in Working Capital | 3.55 M |
| Others | -3.83 M |
| Free Cash Flow | -73.4 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (85.9) | (68.9) | (55.0) | (39.5) | (25.8) | (22.1) | (20.6) | (14.7) | (23.4) | (21.9) | (0.1) | 444 |
| Depreciation & Amortization | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.5 | 1.4 | 1.9 | 1.0 | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 3.9 | 3.8 | 0.5 | (0.4) | (1.3) | (1.8) | (0.9) | 0 | 0 | 0 |
| Stock Based Compensation | 16.8 | 8.7 | 6.1 | 5.8 | 3.7 | 2.6 | 1.5 | 1.8 | 2.6 | 6.26 K | 3.55 | 22.4 |
| Other Operating Activities | (8.1) | 1.3 | 29 K | 0.1 | 0.3 | (0.2) | 2.5 | 0.9 | 11.3 | (1.7) | 42.6 K | 244 |
| Change in Working Capital | 3.5 | 10.2 | (2.9) | 7.7 | (3.8) | 0.8 | 1.8 | 0.8 | 0.6 | 21.9 | 25.4 K | 0 |
| Cash From Operations | (73.4) | (48.4) | (47.6) | (21.8) | (24.8) | (18.8) | (14.8) | (11.1) | (8.7) | (1.6) | 78.2 K | 200 |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Items | (179.1) | 54.8 | 38.0 | 41.6 | 7.5 | (265.7) | (1.7) | 3.0 | (13.5) | 0 | 0 | 0 |
| Cash From Investing Activities | (179.1) | 54.8 | 38.0 | 41.6 | 7.5 | (265.7) | (1.7) | 3.0 | (13.5) | 0 | 0 | 0 |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | (7.1) | (6.8) | 707 | 296 | 151 | 0 | 0 | 229 | 38 | 2 | 2.5 K | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | (3.8) | 77 K | 94.9 K | 0 | 2.5 | 0.3 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 271.4 | 11.0 | 6.9 | 0.9 | 0.9 | 7.5 | 0.1 | (1.1) | (3.2) | (0.3) | 0 | 200 |
| Cash From Financing Activities | 271.4 | 4.2 | 6.9 | 0.9 | 0.9 | 300.3 | 22.4 | 10.3 | 22.2 | 2.2 | 0.3 | 200 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | 18.9 | 10.3 | (2.7) | 20.7 | (16.4) | 15.8 | 5.9 | 2.3 | 12.7 K | 0.6 | 0.2 | 0 |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (73.4) | (48.4) | (47.6) | (21.8) | (24.8) | (18.8) | (14.8) | (11.1) | (8.7) | (1.6) | 78.2 K | 200 |